Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Anxiety drug Clonazepam recalled for mislabeling
Anxiety drug Clonazepam recalled for mislabeling; could cause a 'life-threatening' event
Clonazepam, an anxiety drug, is being voluntarily recalled for the potential to cause a “life-threatening” event.
Popular anxiety drug clonazepam recalled for labeling error
Additional packages of clonazepam, a prescription medication used to treat seizures and anxiety, mislabeled with the incorrect strength have been added to a voluntary recall, according to the U.S. Food and Drug Administration.
Clonazepam Recall Grows Over Potentially Life-Threatening Label Error
Sixteen lots of clonazepam orally disintegrating tablets have been recalled because of a packaging error that could have life-threatening consequences.
Yahoo
1d
Anxiety drug Clonazepam recalled over 'possibly life-threatening' labeling error
According to Endo, Inc.’s
recall
, the
Clonazepam
being recalled is in cartons containing 60
tablets
that are packed ...
WGRZ
5d
Clonazepam recall expanded after misprinting on packaging
The original
recall
of
Clonazepam
Orally Disintegrating
tablets
was issued in July. The company is worried mislabeling could lead to unintentionally taking higher doses, increasing the risk of ...
8d
Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling
Endo, Inc. (OTCQX: NDOI) ("Endo") announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its ...
Monthly Prescribing Reference
8d
More Clonazepam ODT Recalled Due to Carton Strength Mislabeling
Endo has expanded the
recall
of
Clonazepam
Orally Disintegrating
Tablets
(ODT) to include additional lots that may ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback